mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |